Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1
暂无分享,去创建一个
[1] S. Morrison,et al. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region , 1991, The Journal of experimental medicine.
[2] J. Deisenhofer. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.
[3] T. V. van Berkel,et al. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. , 1988, The Journal of biological chemistry.
[4] M. Brüggemann,et al. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q , 1988, The Journal of experimental medicine.
[5] P. Garred,et al. Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration , 1991, European journal of immunology.
[6] G. Sármay,et al. A protein structural change in aglycosylated IgG3 correlates with loss of huFcγR1 and hufcγR111 binding and/or activation , 1990 .
[7] C. Channing,et al. Role of the carbohydrate residues of human chorionic gonadotropin in binding and stimulation of adenosine 3',5'-monophosphate accumulation by porcine granulosa cells. , 1978, Endocrinology.
[8] L. Nelles,et al. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer. , 1991, European journal of biochemistry.
[9] D. Burton,et al. Human antibody effector function. , 1992, Advances in immunology.
[10] P. Stanley. Glycosylation mutants of animal cells. , 1984, Annual review of genetics.
[11] S. Morrison,et al. Structural features of human immunoglobulin G that determine isotype- specific differences in complement activation , 1993, The Journal of experimental medicine.
[12] D. Isenberg,et al. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. , 1992, The Journal of clinical investigation.
[13] R. R. Robinson,et al. Secretion of functional antibody and Fab fragment from yeast cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Matzuk,et al. Expression of recombinant human choriogonadotropin in Chinese hamster ovary glycosylation mutants. , 1989, Molecular endocrinology.
[15] M. J. Mattes. Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications. , 1987, Journal of the National Cancer Institute.
[16] R. Owens,et al. Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells. , 1993, Journal of immunology.
[17] A. Shimizu,et al. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. , 1982, Journal of immunology.
[18] R. Dwek,et al. Immunoglobulin G as a glycoprotein. , 1986, Biochemical Society symposium.
[19] P. Stanley. Glycosylation mutants and the functions of mammalian carbohydrates , 1987 .
[20] S L Morrison,et al. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. , 1989, Journal of immunology.
[21] J. Baynes,et al. Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG-antigen complexes. , 1980, The Journal of biological chemistry.
[22] S. Gillies,et al. Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function. , 1991, Hybridoma.
[23] B. Smedsrød,et al. Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. , 1990, The Biochemical journal.
[24] P. Stanley,et al. Complementation between mutants of CHO cells resistant to a variety of plant lectins , 1977, Somatic cell genetics.
[25] P. Heinrich,et al. Involvement of various organs in the initial plasma clearance of differently glycosylated rat liver secretory proteins. , 1988, European journal of biochemistry.
[26] A. Riggs,et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. , 1990, Cancer research.
[27] S L Morrison,et al. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[28] H. Wigzell,et al. Biological significance of carbohydrate chains on monoclonal antibodies. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[29] S L Morrison,et al. Production and properties of chimeric antibody molecules. , 1989, Methods in enzymology.
[30] P. Casellas,et al. Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin. , 1986, European journal of biochemistry.
[31] M A Kukuruzinska,et al. Protein glycosylation in yeast. , 1987, Annual review of biochemistry.
[32] R. Dwek,et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.
[33] J. Tite,et al. Humanized monoclonal antibody CAMPATH‐1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell‐derived material , 1992, Clinical and experimental immunology.
[34] T Miyamoto,et al. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. , 1989, The Journal of rheumatology.
[35] D R Burton,et al. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. , 1985, Molecular immunology.
[36] H. Lenz,et al. Reconstitution of functionally active antibody directed against creatine kinase from separately expressed heavy and light chains in non-lymphoid cells. , 1987, Gene.
[37] R. Jefferis,et al. A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. , 1990, The Biochemical journal.
[38] D. Phillips,et al. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G. , 1983, Biochemical Society transactions.
[39] C. Bindon,et al. Complement activation by immunoglobulin does not depend solely on C1q binding , 1990, European journal of immunology.